HRH1 and colorectal carcinoma: Hrh1, Hrh2, Hrh3 and Hrh4 antagonists were previously reported to suppress the growth of human CRC in nude mice and chemically-induced colorectal carcinogenesis through suppression of cell proliferation, apoptosis induction and/or immune function [19,24,40].